• [[ Whitepaper ]] Connecting With Rare Disease Patient Communities: Patient Advocates

    laureng Whitepapers April 19, 2018
  • [[Whitepaper ]] Disruptive Innovation in Rare Disease Markets

    laureng Whitepapers April 19, 2018
  • Choosing the Right Channel Strategy for Specialty Product Success

    Karina Kusova Clinical Development, Market Access, Orphan Drug Congress, Supply Chain & Manufacturing, Uncategorized, Whitepapers May 3, 2017
  • [Whitepaper] Challenging Conventional Patient Recruitment and Care Strategies for Rare Disease Studies

    Karina Kusova Clinical Development, Orphan Drug Congress, Uncategorized, Whitepapers April 10, 2017
  • [[whitepaper]] The New Reality: Maximizing Value in Rare Disease Launches

    Karina Kusova Clinical Development, Featured on App, Orphan Drug Congress, Uncategorized, Whitepapers April 6, 2017
  • What’s New in Rare Cancer Research? (Spoiler Alert: A Lot!)

    Karina Kusova Advocacy, Clinical Development, Market Access, Orphan Drug Congress, Orphan Drugs Live October 10, 2016

Subscribe to Total Orphan Drugs

Strategy and innovation in the orphan drugs and rare diseases industry
Navigation
  • Development
  • Regulation
  • Advocacy
  • Market Access
  • Partnering & Investment
  • Whitepapers
  • Events
    • USA
  • Search
commercialization

Tag Archive

Market Access, Orphan Drug Congress / September 1, 2016

Accelerating Commercialization of Rare Disease Treatments

View Post
View Post

[REPORT] How are Big Data Analytics Revolutionizing Rare Disease Patient Discovery & Commercialization Strategies?

In Clinical Development, Orphan Drug Congress, Orphan Drugs Live by Freya SmaleMarch 28, 2016Leave a Comment

Report on how are Big Data Analytics Revolutionizing Rare Disease Patient Discovery & Commercialization Strategies provided by Vencore.  In the world of “traditional” pharma we …

View Post

[WHITEPAPER] In Drugs for Rare Diseases: Early Commercial Thinking = Future Commercial Success

In Market Access, Orphan Drug Congress, Orphan Drugs Live by Freya SmaleFebruary 26, 2016Leave a Comment

In Drugs for Rare Diseases: Early Commercial Thinking = Future Commercial Success By Harris Kaplan  – Red Team Associates Rare Diseases: Growing Business Opportunity Orphan …

View Post

World Orphan Drug Congress LIVE: Commercialization

In Market Access, Orphan Drug Congress, Orphan Drugs Live, Press Release by Freya SmaleApril 23, 2015Leave a Comment

Back in our main conference room, our commercialization segment of the afternoon began. Mark Rothera Chief Commercial Officer of PTC Therapeutics spoke about launching the 1st …

View Post

Overcoming challenges in Rare Disease Health Research and Orphan Drug Program commercialization

In Market Access by Freya SmaleMarch 31, 2015Leave a Comment

Part of forecasting and best thought of at the early stage than just prior to commercialization, this workshop will help you wrap your head around …

Categories

  • Advocacy
  • Clinical Development
  • Featured on App
  • Market Access
  • Orphan Drug Congress
  • Orphan Drugs Live
  • Partnering & Investment
  • Press Release
  • Regulation & Government
  • Reports
  • Supply Chain & Manufacturing
  • Uncategorized
  • Whitepapers
Toggle the Widgetbar
World Orphan Drug Congress USA
  • Home
  • About Us/Advertise